Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05384626
Title	A Study of NVL-655 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Nuvalent Inc.
Indications	Advanced Solid Tumor lung non-small cell carcinoma
Therapies	NUV-655
Age Groups:	child \| senior \| adult
Covered Countries	USA \| GBR \| FRA \| ESP \| CAN \| AUS